Article Text
Editorial
The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left
Statistics from Altmetric.com
Footnotes
Funding This work was supported by National Institutes of Health (K08HL111207-01A1), American Heart Association (AHA 15GRNT25080016), Cardiovascular Medical Research and Education Foundation (CMREF) and the Klarman Foundation (Boston, Massachusetts, USA) at Brigham and Women's Hospital.
Competing interests BAM receives funding from Gilead Sciences Inc. to study pulmonary hypertension.
Provenance and peer review Commissioned; internally peer reviewed.